Are experimental models useful for analysis of pathogenesis of changes in central nervous system in human diabetes?

Folia Neuropathologica

Volumn 41, Issue 3, 2003, Pages 167-174

  Piotrowski, Piotr ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Brain; Hyperglycaemia; Nervous system; Streptozotocin

Indexed keywords

ALLOXAN; ANTIOXIDANT; INSULIN; LIPID; ORAL ANTIDIABETIC AGENT; STREPTOZOCIN;

AGING; BIOCHEMISTRY; BLOOD VESSEL WALL; BRAIN BLOOD FLOW; CATARACT; CELL METABOLISM; CENTRAL NERVOUS SYSTEM; CLINICAL OBSERVATION; COGNITIVE DEFECT; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE DURATION; ELECTROPHYSIOLOGY; ENDOTHELIUM; EXPERIMENTAL DIABETES MELLITUS; EXPERIMENTAL MODEL; HUMAN; HYPERGLYCEMIA; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; LIPID PEROXIDATION; NEUROPSYCHOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; STREPTOZOCIN DIABETES; VASCULAR DISEASE;

EID: 0142126165     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Adolphe AB, Glasofer ED, Troetel WM, Ziegenfuss J, Stambaugh JE, Weiss AJ, Manthei RW (1975) Fate of streptozotocin (NSC-85998) in patients with advanced cancer. Cancer Chemother Rep, 59: 547-556.
2. Affolter V, Boujon P, Bestetti G, Rossi GL (1986) Hypothalamic and cortical neurons of normotensive and spontaneously hypertensive rats are differently affected by streptozotocin diabetes. Acta Neuropathol (Berl.), 70: 135-141.
3. Ahmad S, Eisa AK (1998) Streptozotocin-induced diabetes enhances protective effects of enalapril on nitric oxide-deficient stroke in stroke-prone rats. Life Sci, 63: 2353-2363.
4. Alex M, Baron EK, Goldenberg S, Blumenthal HT (1962) An autopsy study of cerebrovascular accidents in diabetes mellitus. Circulation, 25: 663-673.
5. Allison J, Campbell IL, Morahan G, Mandel TE, Harrison LC, Miller JF (1988) Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic beta cells. Nature, 333: 529-533.
6. Arison RN, Ciaccio EI, Glitzer MS, Cassaro JA, Pruss MP, Rahway BS (1967) Light end electron microscopy of lesions in rats rendered diabetic with streptozotocin. Diabetes, 16: 51-56.
7. Betsen N, Larsen B, Lassen NA (1975) Chronically impaired autoregulation of cerebral blood flow in long-term diabetics. Stroke, 6: 497-502.
8. Bhardwaj SK, Kaur G (1999) Effect of diabetes on calcium/calmodulin dependent protein kinase-II from rat brain. Neurochem Int, 35: 329-335.
9. Bhuyan BK, Kuentzel SL, Gray LG, Fraser TJ, Wallach D, Neil GL (1974) Tissue distribution of streptozotocin (NSC-85998). Cancer Chemother Rep, 58: 157-165.
10. Biessels GJ, Kamal A, Ramakers GM, Urban IJ, Spruijt BM, Erkelens DW, Gispen WH (1996) Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes, 45: 1259-1266.
11. Biessels GJ, Van Dam PS (1997) Diabetic neuropathy: Pathogenesis and current treatment perspectives. Neuroscience Res Commun, 10: 1-10.
12. Bliss TV, Collingridge GL (1939) A synaptic model of memory: Long-term potentiation in the hippocampus. Nature, 361: 31-39.
13. Cattabeni F, Gardoni F, Di Luca M (1999) Pathophysiological implications of the structural organization of the excitatory synapse. Eur J Pharmacol, 375: 339-347.
14. Craft S, Murphy C, Wemstrom J (1994) Glucose effects on complex memory and nonmemory tasks: The influence of age, sex, and glucoregulatory response. Psychobiology, 22: 95-105.
15. Crisa L, Mordes JP, Rossini AA (1992) Autoimmune diabetes mellitus in the BB rat. Diabetes Metab Rev, 8: 9-37.
16. Curtis GW, Robbins SL, Glickman DMD (1947) Studies on glycogen nephrosis in alloxan-treated diabetic rats. J Exp Med, 85: 373-379.
17. Dejgaard A, Gade A, Larsson H, Balle V, Parving A, Parving HH (1991) Evidence for diabetic encephalopathy. Diabetic Med, 8: 162-167.
18. Di Mario U, Morano S, Valle E, Pozzessere G (1995) Electrophysiological alterations of the central nervous system in diabetes mellitus. Diabetes Metab Rev, 11: 259-278.
19. Duckrow RB, Beard DC, Brennan RW (1987) Regional cerebral blood flow decreases during chronic and acute hyperglycemia. Stroke, 18: 52-58.
20. Dyck PJ, Zimmerman RB, Vilen TH, Minnerath SR, Karnes JL, Yao JK, Poduslo JF (1988) Nerve glucose, fructose, sorbitol, myoinositol and fiber degeneration and regeneration in diabetic neuropathy. N Engl J Med 319: 542-548.
21. Ferreira FM, Palmeira CM, Matos MJ, Seica R, Santos MS (1999) Decreased susceptibility to lipid peroxidation of Goto-Kakizaki rats: Relationship to mitochondrial antioxidant capacity. Life Sci, 65: 1013-1025.
22. Folbergrova J, Memezawa H, Smith ML, Siesjo BK (1992) Focal and perifocal changes in tissue energy state during middle cerebral artery occlusion in normo- and hyperglycemic rats. J Cereb Blood Flow Metab, 12: 25-33.
23. Frerichs H, Creutzfeldt W (1971) Der experimentalle chemische diabetes. In Dörzbach E (ed.). Insulin I. Springer Verlag, Berlin-Heidelberg: 159.
24. Greene D, Lattimer S (1983) Impairment rat sciatic nerve soddium-potassium adenosine triphosphatase in acute streptozotocin diabetes and its correction by dietary myo-inositol supplementation. J Clin Invest, 72: 1058.
25. Helkala E-L, Niskanen L, Viinamaki H, Partanen J, Uusitupa M (1995) Short-term and long-term memory in elderly patients with NIDDM. Diabetes Care, 18: 681-685.
26. Herr RR, Eble TE, Bergy ME, Jahnke HK (1959-1960) Isolation and characterization of streptozotocin. Antibiot Ann, 7: 236-240.
27. Ito M, Kondo Y, Nakatani A, Naruse A (1999) New model of progressive non-insulin-dependent diabetes mellitus. Biol Pharm Bull, 22: 988-989.
28. Jain SK (1989) Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells. J Biol Chem, 264: 21340-21345.
29. Jain SK, McVie R (1994) Effect of glycemic control, race (white versus black), and duration of diabetes on reduced glutathione content in erythrocytes of diabetic patients. Metabolism, 43: 306-309.
30. Jakobsen J, Sidenius P, Gundersen HJ, Osterby R (1987) Quantitative changes of cerebral neocortical structure in insulin-treated long-term streptozotocin-induced diabetes in rats. Diabetes, 36: 597-601.
31. Junod A, Lambert AE, Orci L, Pictet R, Gonet AE, Renold AE (1967) Studies of the diabetogenic action of streptozotocin. Proc Soc Exp Biol Med, 126: 201-205.
32. King GL, Brownlee M (1996) The cellular and molecular mechanisms of diabetic complications. Endocrinol Metab Clin North Am, 25: 255-270.
33. King GL, Shiba T, Oliver J, Inoguchi T, Bursell SE (1994) Cellular and molecular abnormalities in the vascular endothelium of diabetes mellitus. Annu Rev Med, 45: 179.
34. Kuroda S, Janelidze S, Siesjö BK (1999) The immunosuppressants cyclosporin A and FK506 equally ameliorate brain damage due to 30-min middle cerebral artery occlusion in hyperglycemic rats. Brain Res, 835: 148-153.
35. Kushner B, Lazar M, Furman M, Lieberman TW, Leopold IH (1969) Resistance of rabbits and guinea pigs to the diabetogenic effect of streptozotocin. Diabetes, 18: 542-544.
36. Lenzen S, Panten U (1988) Alloxan: History and mechanism of action. Diabetologia, 31: 337-342.
37. Li C, Li PA, He QP, Ouyang YB, Siesjo BK (1998) Effects of streptozotocin-induced hyperglycemia on brain damage following transient ischemia. Neurobiol Dis, 5: 117-128.
38. Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y (1980) Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu, 29: 1-13.
39. Manning CA, Hall JL, Gold PE (1990) Glucose effects on memory and other neuropsychological tests in elderly humans. Psychol Sci, 5: 307-311.
40. Mayhan WG (1993) Cerebral circulation during diabetes mellitus. Pharmac Ther, 57: 377-391.
41. Mordes JP, Rossini AA (1981) Animal models of diabetes. Am J Med, 70: 353-360.
42. Morel DW, Chisolm GM (1989) Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. J Lipid Res, 30: 1827-1834.
43. Mukherjee B, Mukherjee JR, Chatterjee M (1994) Lipid peroxidation, glutathione levels and changes in glutathione-related enzyme activities in streptozotocin-induced diabetic rats. Immun Cell Biol, 72: 109-114.
44. Naritomi H, Meyer JS, Sakai F, Yamaguchi F, Shaw T (1979) Effects of advancing age on regional cerebral blood flow. Studies in normal subjects with risk factors for atherothrombotic stroke. Arch Neurol, 36: 410-416.
45. Piotrowski P, Wierzbicka K, Śmiałek M (2001) Neuronal death in the rat hippocampus in experimental diabetes and cerebral ischaemia treated with antioxidants. Folia Neuropathol, 39: 147-154.
46. Piotrowski P (1999) Morphology of experimental diabetes and cerebral ischemia in the rat brain. Folia Neuropathol, 37: 252-255.
47. Pieper AA, Brat DJ, Krug DK, Watkins CC, Gupta A, Blackshaw S, Verma A, Wang Z-Q, Snyder SH (1998) Poly (SDP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. Proc Natl Acad Sci USA, 96: 3059-3064.
48. Pulsinelli WA, Waldman S, Rawlinson D, Plum F (1982) Moderate hyperglycemia augments ischemic brain damage: A neuropathologic study in the rat. Neurology, 32: 1239-1246.
49. Rakieten N, Rakieten ML, Nadkarni V (1963) Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother Rep, 29, 91-98.
50. Rossini AA, Williams RM, Appel MC, Like AA (1978) Complete protection from low-dose streptozotocin-induced diabetes in mice. Nature, 276: 182-184.
51. Sato Y, Hotta N, Sakamoto N (1979) Lipid peroxide level in plasma of diabetic patients. Biochem Med, 21: 104-107.
52. Seibert K, Golub G, Smiledge P, Nystrom JS (1979) Continuous streptozotocin infusion: A phase I study. Cancer Treat Rep, 63: 2035-2037.
53. Sieber FE, Martin LJ, Brown PR, Palmon SC, Traystman RJ (1996) Diabetic chronic hyperglycemia and neurologic outcome following global ischemia in dogs. J Cereb Blood Flow Metab, 16: 1230-1235.
54. Stone WS, Wenk GL, Olton DS, Gold PE (1990) Poor glucose regulation predicts sleep and memory deficits in normal aged rats. J Gerontol Biol Sci, 45: B169-B173.
55. Suzuki W, Iizuka S, Tabuchi M, Funo S, Yanagisawa T, Kimura M, Sato T, Endo T, Kawamura H (1999) A new mouse model of spontaneous diabetes derived from ddY strain. Exp Anim, 48: 181-189.
56. Tanaka Y, Gleason CE, Tran PO, Harmon JS, Robertson RP (1999) Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci USA, 96: 10857-10862.
57. Theriault BR, Thistlethwaite JR Jr, Levisetti MG, Wardrip CL, Szot G, Bruce DS, Rilo H, Li X, Gray GS, Bluestone JA, Padrid PA (1999) Induction, maintenance and reversal of streptozotocin-induced insulin-dependent diabetes mellitus in the juvenile cynomolgus monkey (Macaca fascicularis). Transplantation, 68: 331-337.
58. Weir GC, Clare ET, Zmachinski CJ, Bonner-Weir S (1981) Islet secretion in a new experimental model for non-insulin-dependent diabetes. Diabetes, 30: 590-595.
59. Wolff SP, Jiang ZY, Hunt JV (1991) Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic Biol Med, 10: 339-352.